Churchill Management Corp Abbott Laboratories Transaction History

Churchill Management Corp

$8.64 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$102.07 - $123.37 $121,973 - $147,427	-1,195 Reduced 1.98%	59,082 $6.42 Million
Q1 2022 Apr 12, 2022	BUY	$114.02 - $139.04 $28,048 - $34,203	246 Added 0.41%	60,277 $7.13 Million
Q4 2021 Jan 11, 2022	BUY	$115.53 - $141.46 $190,508 - $233,267	1,649 Added 2.82%	60,031 $8.45 Million
Q3 2021 Oct 13, 2021	SELL	$116.66 - $129.06 $80,028 - $88,535	-686 Reduced 1.16%	58,382 $6.9 Million
Q2 2021 Jul 08, 2021	SELL	$105.79 - $124.53 $1.94 Million - $2.29 Million	-18,350 Reduced 23.7%	59,068 $6.85 Million
Q1 2021 Apr 08, 2021	SELL	$108.84 - $128.23 $294,847 - $347,375	-2,709 Reduced 3.38%	77,418 $9.28 Million
Q4 2020 Jan 13, 2021	SELL	$105.0 - $114.42 $564,690 - $615,350	-5,378 Reduced 6.29%	80,127 $8.77 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $419,161 - $509,040	-4,574 Reduced 5.08%	85,505 $9.31 Million
Q2 2020 Jul 17, 2020	BUY	$76.57 - $98.0 $3.72 Million - $4.76 Million	48,617 Added 117.26%	90,079 $8.24 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $213,588 - $312,324	-3,400 Reduced 7.58%	41,462 $3.27 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $51,502 - $57,334	-656 Reduced 1.44%	44,862 $3.9 Million
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $235,290 - $255,127	-2,875 Reduced 5.94%	45,518 $3.81 Million
Q2 2019 Jul 10, 2019	SELL	$72.88 - $85.0 $54,951 - $64,090	-754 Reduced 1.53%	48,393 $4.07 Million
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $171,311 - $207,115	-2,587 Reduced 5.0%	49,147 $3.93 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $491,831 - $557,173	-7,502 Reduced 12.66%	51,734 $3.74 Million
Q3 2018 Oct 05, 2018	BUY	$60.81 - $73.36 $476,385 - $574,702	7,834 Added 15.24%	59,236 $4.35 Million
Q2 2018 Jul 10, 2018	BUY	$57.57 - $63.54 $435,920 - $481,124	7,572 Added 17.28%	51,402 $3.14 Million
Q1 2018 Apr 13, 2018	BUY	$56.27 - $63.62 $615,762 - $696,193	10,943 Added 33.27%	43,830 $2.63 Million
Q4 2017 Jan 11, 2018	BUY	$53.68 - $57.47 $405,606 - $434,243	7,556 Added 29.83%	32,887 $1.88 Million
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $1.22 Million - $1.36 Million	25,331	25,331 $1.35 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Churchill Management Corp with notifications on news.

Account